Post Profile

The Broader Lessons of the EpiPen Debacle

The recent controversy over EpiPen pricing has caused appropriate dismay among Americans who recognize the serious risks involved for allergic individuals. The controversy also provides an important opportunity to better understand the issues underlying pharmaceutical pricing in the United States. The epinephrine auto-injector (EAI) market in this country is a remarkable microcosm of almost every issue involved and those that are currently haunting pharmaceutical market policies in the United States; access challenges, rapidly growing affordability barriers, lack of meaningful competition, and limited innovation.
read more


Related Posts

Here's what the EpiPen maker says about why it won't just cut the drug's price (MYL)

Business & Finance : Business Insider: Money Game

The pharmaceutical company in hot water over the price of the EpiPen just answered a major question on everyone's minds.  Why doesn't it just cut the price? The EpiPen, a device used in emergencies to treat severe allergic reactions...

Mylan Executives Got Pay Increases As Price Of EpiPen Soared

News : Huffington Post

As the pharmaceutical company Mylan raised the price of the EpiPen, a device commonly used to counter allergic reactions, company executives got a big bump in compensation. From 2007 to 2015, the company’s stock price more than trip...

Mylan CEO Says EpiPen Price Increase Makes ‘The World A Better Place’

News : The Inquisitr - News

The recent EpiPen price hike has placed an unexpected financial burden on families and allergy sufferers across the nation. The price hike came at a time that parents would likely be purchasing an extra set of EpiPens for schools an...

Joe Manchin, Whose Daughter Runs EpiPen Manufacturer, Breaks Silence On Drug’s Price Hike

News : Huffington Post

Sen. Joe Manchin (D-W.Va.) has finally addressed the controversy involving his daughter, who runs a pharmaceutical company that dramatically hiked the prices of lifesaving EpiPens. Manchin’s daughter, Heather Bresch, is the CEO of M...

EpiPens' price jumped more than 500%, and lawmakers want to know why

Issues & Causes / Environmentalism : Greenspace

Lawmakers are demanding more information on why the price for lifesaving EpiPens has skyrocketed. EpiPens are used to ward off potentially fatal allergic reactions, and their price has surged in recent years. A two-dose package cost...


Copyright © 2016 Regator, LLC